InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Browse the full record of transactions filed by Schwartz Aharon. Director active across 1 company, notably Protalix BioTherapeutics, Inc.. Aggregated, 1 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €146k. Activity tracked since 3 January 2023. The latest transaction was disclosed on 3 January 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration